Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Curon Medical Inc.

www.curonmedical.com

Latest From Curon Medical Inc.

Transoral GERD Devices: Riding Out The Road To Reimbursement

With health care becoming increasingly data driven, third-party payors are requiring a higher level of evidence before making a positive coverage determination for a new technology or procedure. This has made the road to reimbursement much longer and tougher for device companies in general, and manufacturers of transoral devices for GERD are a prime example.

Medical Device North America

SAGES 2010: Barrett's Esophagus Still a Conundrum for Surgeons

At the recent 12th World Congress of Endoscopic Surgery, hosted by the Society of American Gastrointestinal and Endoscopic Surgeons, physicians discussed the challenges of identifying patients at risk of esophageal cancer. Barrett’s esophagus has long been known as a risk factor, but it remains a mystery as to how to predict which patients with Barrett’s will progress to esophageal cancer and who to screen in order to prevent it,

Novasys: Using Clinical Trials to Drive Adoption for Incontinence

Novasys Medical is using radio frequency (RF) energy to treat stress urinary incontinence in women. The company chose to adopt a much more rigorous and expensive clinical trials strategy than was needed to gain FDA approval of its device. This approach flummoxed the FDA,, slowing approval of the company's IRenessaI system. Novasys is betting that the enhanced data collected from its clinical study will result in the company gaining faster reimbursement that it hopes will drive adoption.
Medical Device Strategy

EndoGastric Solutions: Re-Inventing GERD Therapy

EndoGastric Solutions has found a new approach to GERD surgery: trans-orally with an endoluminal approach. The new procedure should go minimally-invasive surgery one better, but in the process opens up a huge debate: will endoluminal GERD surgery be the province of gastric surgeons or gastroenterologists?
Medical Device Innovation
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Conway Stuart Medical Inc.
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Curon Medical Inc.
  • Senior Management
  • Carlos Babini, VP, Sales
    Gary Tegan, VP, Mktg.
    David Utley, MD, Chief Medical Officer
  • Contact Info
  • Curon Medical Inc.
    Phone: (408) 733-9910
    735 Palomar Ave.
    Sunnyvale, CA 94085
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register